Skip to search boxSkip to navigationSkip to main content

Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort

Research Output: Contribution to journal Article Peer-review

Open access

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Article number

e000641

Journal (Volume, Issue Number)

Lupus Science and Medicine (Volume 9, Issue 1)

Publication milestones

  • Published - 2022

Publication status

Published - 2022

Publication IDs

  • Scopus: 85158824910

Abstract

Background Flares in patients with SLE, regardless of their severity, have been associated with damage accrual. However, their impact on health-related quality of life (HRQoL) has not been fully evaluated. In fact, disease activity is only minimally associated with HRQoL. Objective To determine the association between flares and HRQoL. Methods Patients from the Almenara Lupus Cohort were included. Visits occurring between December 2015 and February 2020 were evaluated. Flares were defined as an increase on the SLE Disease Activity Index 2000 (SLEDAI-2K) of at least 4 points; severe flares were those with a final SLEDAI-2K ≥12 and mild-moderate flares all the others. HRQoL was measured using the LupusQoL. Univariable and multivariable generalised estimating regression equations were performed, adjusting for possible confounders. Confounders were determined at one visit, whereas the outcome was determined on the subsequent visit; flares were determined based on the variation of the SLEDAI-2K between these visits. Results Two hundred and seventy-seven patients were included; 256 (92.4%) were female, mean age at diagnosis was 36.0 (SD: 13.3) years and mean disease duration at baseline was 9.1 (SD: 7.1) years. Patients had mean of 4.8 (SD: 1.9) visits and a mean follow-up of 2.7 (1.1) years. Out of 1098 visits, 115 (10.5%) flares were defined, 17 were severe and 98 mild-moderate. After adjustment for possible confounders, only severe flares were associated with a poorer HRQoL in planning, pain, emotional health and fatigue. Conclusions Severe flares, but not mild-moderate, flares are associated with poorer HRQoL.

Funding Details

Additionally, the Almenara Lupus Cohort has been partially supported by institutional grants from EsSalud (1483-GCGP-ESSALUD-2013, 1733-GCGP-ESSALUD-2014 and the 2015 Kaelin Prize 04-IETSI-ESALUD-2016), from the Pan American League of Associations for Rheumatology (PANLAR) (2015 PANLAR Prize and the 2018 H Ralph Schumacher MD/JCR/PANLAR Prize) and from the Fundación Instituto Hipólito Unanue. Competing interests MFU-G has grant support from Janssen and Pfizer. RVG-C has grant support from Pfizer. CR-S and VRP-Q have grant support from Janssen. FZ and CSK are employees of Janssen Scientific Affairs. All other authors declare to have no other conflicts of interest. Patient and public involvement The Almenara Lupus Cohort used focus groups, interviews and questionnaires to determine the patients’ priorities and preferences including which outcomes are relevant to them, and if there are any problems with the instruments used or the length of the visits. Patients are involved in recruitment Funding These analyses were done as a part of a research grant from Janssen.
FundersFunding numbers
EsSalud
-
Janssen Pharmaceuticals
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Mentions
2
Social media
15
Captures
18
Citations
8